A new 45,000 tons ISOPROPANOL production facility
The new ISOPROPANOL unit will be based on the Roussillon platform (Isere, France), a best-in-class platform in terms of competitiveness fully committed to a low carbon energy transition.
Guaranteeing domestic manufacturing of one of the main solvents used in the production of pharmaceutical ingredients
The unit will have a capacity of 45 000 tons and is scheduled to come on stream early in 2022. It will guarantee domestic production, even in times of health crises
, of one of the main solvents used in the production of intermediates and pharmaceutical active ingredients, as well as in hygiene, disinfection and sanitizing products (such as hydro-alcoholic solutions and gels).
A production unit with new energetic standards
Thanks to this investment, SEQENS will continue its downstream integration by offering a large range of ISOPROPANOL grades, from Pharmaceutical, Cosmetic, Technical, and very recently, Electronic and Biocide grades, to support our end-markets, as well our specialty solvents such as ISOPROPYL-ACETATE and DI-ISOPROPYL-ETHER.
Furthermore, this new unit will set a new standard
for energy efficiency with a two-thirds reduction in energy consumption
compared to the best international reference
s and standards.
This new development will strengthen the Roussillon platform, where SEQENS is one of the main industrial players.